These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Yellow light on pain relievers. American Heart Association guidelines recommend using caution for all medications that ease pain. Harv Heart Lett; 2007 Jun; 17(10):1-3. PubMed ID: 17654797 [No Abstract] [Full Text] [Related]
5. NSAIDS and the risk of myocardial infarction: do they help or harm? Bhatt DL Eur Heart J; 2006 Jul; 27(14):1635-6. PubMed ID: 16782714 [No Abstract] [Full Text] [Related]
6. Coxib medications to be handled with care. Misak A CMAJ; 2005 Feb; 172(3):330. PubMed ID: 15615922 [No Abstract] [Full Text] [Related]
8. [Do selective COX-2-inhibitors increase the risk of myocardial infarction?]. Otterstad JE Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3434-5. PubMed ID: 14713991 [No Abstract] [Full Text] [Related]
9. Celecoxib shown effective in preventing colon polyps. Nelson NJ J Natl Cancer Inst; 2006 May; 98(10):665-7. PubMed ID: 16705118 [No Abstract] [Full Text] [Related]
10. Balancing the risks and benefits of celecoxib. Caldwell B; Beasley R; Weatherall M; Metcalfe S Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734 [No Abstract] [Full Text] [Related]
11. [A reply: Not without costs to prevent hundreds of NSAID-related fatal cases]. Wollheim F Lakartidningen; 2000 Jul; 97(30-31):3415. PubMed ID: 11016215 [No Abstract] [Full Text] [Related]
12. Naproxen still rules. Duke Med Health News; 2007 Jan; 13(1):2. PubMed ID: 17301989 [No Abstract] [Full Text] [Related]
13. Naproxen-induced ST-elevation myocardial infarction in a 33-year-old man. Abuzetun JY; Satpathy R; Suker M; Elder M; Mooss A J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):471-3. PubMed ID: 20739900 [No Abstract] [Full Text] [Related]
14. Risk assessment, drug approval, and liability. Somberg JC Am J Ther; 2006; 13(3):181-2. PubMed ID: 16772756 [No Abstract] [Full Text] [Related]
15. Vioxx removed from market. Mayo Clin Womens Healthsource; 2004 Dec; 8(12):3. PubMed ID: 15592151 [No Abstract] [Full Text] [Related]
16. Evaluating drug effects in the post-Vioxx world: there must be a better way. Avorn J Circulation; 2006 May; 113(18):2173-6. PubMed ID: 16684873 [No Abstract] [Full Text] [Related]
17. Could Bextra increase heart risks too? Health News; 2004 Dec; 10(12):2. PubMed ID: 15645556 [No Abstract] [Full Text] [Related]
18. Pain drugs and heart attack. What's your risk? Mayo Clin Health Lett; 2013 Apr; 31(4):6. PubMed ID: 24696897 [No Abstract] [Full Text] [Related]
19. Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now. Finckh A; Aronson MD Ann Intern Med; 2005 Feb; 142(3):212-4. PubMed ID: 15684210 [No Abstract] [Full Text] [Related]
20. Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Abraham NS; El-Serag HB; Hartman C; Richardson P; Deswal A Aliment Pharmacol Ther; 2007 Apr; 25(8):913-24. PubMed ID: 17402995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]